Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $3.6400 (-0.27%) ($3.6400 - $3.6400) on Mon. Jan. 24, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.47% (three month average) | RSI | 15 | Latest Price | $3.6400(-0.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.3% a day on average for past five trading days. | Weekly Trend | CGEN declines -6.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(85%) ARKK(82%) ARKG(81%) IBUY(81%) IWO(81%) | Factors Impacting CGEN price | CGEN will decline at least -2.235% in a week (0% probabilities). VIXM(-72%) VXX(-53%) UUP(-27%) UNG(-14%) EDOC(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.235% (StdDev 4.47%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-8.58(-335.71%) | Resistance Level | $4.08 | 5 Day Moving Average | $3.74(-2.67%) | 10 Day Moving Average | $3.88(-6.19%) | 20 Day Moving Average | $4.08(-10.78%) | To recent high | -49.2% | To recent low | 0% | Market Cap | $301m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |